These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27009354)

  • 1. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.
    Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J
    Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
    Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M; Rutqvist LE; Johansson H
    Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
    Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
    Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
    Bevier M; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
    Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
    Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
    Shu X; Sundquist K; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time trends in survival from cancer of unknown primary: small steps forward.
    Riihimäki M; Hemminki A; Sundquist K; Hemminki K
    Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.
    Binder C; Matthes KL; Korol D; Rohrmann S; Moch H
    Cancer Med; 2018 Sep; 7(9):4814-4824. PubMed ID: 30019510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer of unknown primary is associated with diabetes.
    Hemminki K; Försti A; Sundquist K; Li X
    Eur J Cancer Prev; 2016 May; 25(3):246-51. PubMed ID: 26011105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific survival rates for cancer of unknown primary according to location of metastases.
    Hemminki K; Riihimäki M; Sundquist K; Hemminki A
    Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
    Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
    Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
    Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
    Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid reduction in the incidence of cancer of unknown primary. A population-based study.
    Brustugun OT; Helland Å
    Acta Oncol; 2014 Jan; 53(1):134-7. PubMed ID: 23550957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data.
    Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA
    Cancer Epidemiol; 2014 Aug; 38(4):460-4. PubMed ID: 24929356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
    Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
    Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
    Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
    PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes following craniotomy for intracranial metastases from an unknown primary.
    Gough M; Nielsen M; Coulter IC; Holliman D
    Int J Clin Oncol; 2020 Aug; 25(8):1475-1482. PubMed ID: 32358736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IV melanoma of unknown primary: A population-based study in the United States from 1973 to 2014.
    Scott JF; Conic RZ; Thompson CL; Gerstenblith MR; Bordeaux JS
    J Am Acad Dermatol; 2018 Aug; 79(2):258-265.e4. PubMed ID: 29580859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site.
    Riihimäki M; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2014 Jun; 14():439. PubMed ID: 24929562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.